Our scientific knowledge of bullous pemphigoid (BP) has dramatically progressed in recent years. However, despite the availability of various therapeutic options for the treatment of inflammatory diseases, only a few multicenter controlled trials have helped to define effective therapies in BP. A major obstacle in sharing multicenter-based evidences for therapeutic efforts is the lack of generally accepted definitions for the clinical evaluation of patients with BP. Common terms and end points of BP are needed so that experts in the field can accurately measure and assess disease extent, activity, severity, and therapeutic response, and thus facilitate and advance clinical trials. These recommendations from the International Pemphigoid Committee represent 2 years of collaborative efforts to attain mutually acceptable common definitions for BP and proposes a disease extent score, the BP Disease Area Index. These items should assist in the development of consistent reporting of outcomes in future BP reports and studies. © 2011 by the American Academy of Dermatology, Inc.
Definitions and outcome measures for bullous pemphigoid: Recommendations by an international panel of experts / Murrell, D. F.; Daniel, B. S.; Joly, P.; Borradori, L.; Amagai, M.; Hashimoto, T.; Caux, F.; Marinovic, B.; Sinha, A. A.; Hertl, M.; Bernard, P.; Sirois, D.; Cianchini, G.; Fairley, J. A.; Jonkman, M. F.; Pandya, A. G.; Rubenstein, D.; Zillikens, D.; Payne, A. S.; Woodley, D.; Zambruno, G.; Aoki, V.; Pincelli, C.; Diaz, L.; Hall, R. P.; Meurer, M.; Mascaro, Jr. J. M.; Schmidt, E.; Shimizu, H.; Zone, J.; Swerlick, R.; Mimouni, D.; Culton, D.; Lipozencic, J.; Bince, B.; Grando, S. A.; Bystryn, J. -C.; Werth, V. P.. - In: JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. - ISSN 0190-9622. - 66:3(2012), pp. 479-485. [10.1016/j.jaad.2011.06.032]
Definitions and outcome measures for bullous pemphigoid: Recommendations by an international panel of experts
Pincelli C.;
2012
Abstract
Our scientific knowledge of bullous pemphigoid (BP) has dramatically progressed in recent years. However, despite the availability of various therapeutic options for the treatment of inflammatory diseases, only a few multicenter controlled trials have helped to define effective therapies in BP. A major obstacle in sharing multicenter-based evidences for therapeutic efforts is the lack of generally accepted definitions for the clinical evaluation of patients with BP. Common terms and end points of BP are needed so that experts in the field can accurately measure and assess disease extent, activity, severity, and therapeutic response, and thus facilitate and advance clinical trials. These recommendations from the International Pemphigoid Committee represent 2 years of collaborative efforts to attain mutually acceptable common definitions for BP and proposes a disease extent score, the BP Disease Area Index. These items should assist in the development of consistent reporting of outcomes in future BP reports and studies. © 2011 by the American Academy of Dermatology, Inc.File | Dimensione | Formato | |
---|---|---|---|
Bolle Murrel.pdf
Accesso riservato
Tipologia:
Versione pubblicata dall'editore
Dimensione
790.3 kB
Formato
Adobe PDF
|
790.3 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
POST PRINT.pdf
Open access
Tipologia:
Versione dell'autore revisionata e accettata per la pubblicazione
Dimensione
1.24 MB
Formato
Adobe PDF
|
1.24 MB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris